Biomarkers of Cancer
Publisher
Springer New York
Reference279 articles.
1. Abuzeid WM, Davis S, Tang AL, et al. Sensitization of Head and Neck Cancer to Cisplatin Through the Use of a Novel Curcumin Analog. Arch Otolaryngol Head Neck Surg 2011;137:499-507.
2. Ahel D, Horejsi Z, Wiechens N, et al. Poly(ADP-ribose)-Dependent Regulation of DNA Repair by the Chromatin Remodeling Enzyme ALC1. Science 2009;325:1240-3.
3. Aivado M, Spentzos D, Germing U, et al. Serum proteome profiling detects myelodysplastic syndromes and identifies CXC chemokine ligands 4 and 7 as markers for advanced disease. PNAS 2007;104:1307-12.
4. Ali SM, Carney WP, Esteva FJ, et al. Serum HER-2/neu and relative resistance to trastuzumab-based therapy in patients with metastatic breast cancer. Cancer 2008;113:1294-301.
5. Al-Saffar NM, Troy H, Ramirez de Molina A, et al. Noninvasive magnetic resonance spectroscopic pharmacodynamic markers of the choline kinase inhibitor MN58b in human carcinoma models. Cancer Res 2006;66:427-34.